Search Results
575 items found for "G-protein coupled receptors (GPCRs)"
- Novo Nordisk moves to strengthen obesity efforts
Re ad more at the source #DrGPCR #GPCR #IndustryNews
- Discovery On Target, October 17-20, 2022, Boston, USA
Read more at the source #DrGPCR #GPCR #IndustryNews
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric Read more at the source #DrGPCR #GPCR #IndustryNews
- Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
" Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Reports Second Quarter 2022 Results and Provides Business Update
Read more at the source #DrGPCR #GPCR #IndustryNews
- ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
media at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) the same day. " Read more at the source #DrGPCR #GPCR
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
Read more at the source #DrGPCR #GPCR #IndustryNews
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
position as Scientific co-founder LASEREDD Therapeutics " Ross Bathgate Read more at the source #DrGPCR #GPCR
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
Read more at the source #DrGPCR #GPCR #IndustryNews
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
Read more at the source #DrGPCR #GPCR #IndustryNews
- Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
Read more at the source #DrGPCR #GPCR #IndustryNews
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
authorization for the Company’s TAVNEOS (avacopan), an orally administered selective complement 5a receptor Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Read more at the source #DrGPCR #GPCR #IndustryNews
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Read more at the source #DrGPCR #GPCR #IndustryNews
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
ADX71149 is a selective metabotropic glutamate type 2 (mGlu2) receptor positive allosteric modulator potential global development of ADX71149 for the treatment of epilepsy. " Read more at the source #DrGPCR #GPCR
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Raises $10 Million In Equity Financing
Read more at the source #DrGPCR #GPCR #IndustryNews
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
" Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
for Charcot-Marie-Tooth type 1A neuropathy (CMT1A) and pain. " Read more at the source #DrGPCR #GPCR
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
Read more at the source #DrGPCR #GPCR #IndustryNews